OVERVIEW

National Lipid Association Self-Assessment Program (NLA-SAP) Sixth Edition is organized by National Lipid Association (NLA).

Release Date: May 31, 2023
Expiration Date: May 31, 2026

Program Overview:
The NLA-SAP will evaluate your clinical knowledge of the core curriculum in clinical lipidology as well as challenge your problem-solving skills in the diagnosis and management of patients with dyslipidemia. The NLA-SAP is an online self-assessment program. Modules can be completed from any computer, tablet or device with internet access. Each module contains multiple-choice questions. Participants answer each question and receive immediate feedback including the correct answer, the rationale for the correct answer and references for additional study. Each question’s rationale is based on the most current, peer-reviewed published information to help you strengthen and reinforce your knowledge.

Educational Objectives:
At the conclusion of these activities, all participants should be able to:

Module 1 – The Science of Lipidology: Lipid Metabolism, Pathogenesis of Atherosclerosis and Genetic Disorders

  • Describe the pathophysiology of lipoprotein metabolism.
  • Review genetic disorders affecting lipoprotein metabolism and their molecular etiology.
  • Review genetic mutations of hereditary dyslipidemias.
  • Examine the pathogenesis of atherosclerotic plaque development and progression.
  • Recognize the role of inflammation in atherosclerosis.
  • Examine primary and secondary causes of dyslipidemia.
  • Evaluate representative clinical cases in the management of patients with dyslipidemia.

Module 2 – Evidence-based Medicine and Statistics: ASCVD Risk Assessment and Risk Indicators and Subclinical Atherosclerosis Detection

  • Identify risk factors associated with ASCVD
  • Recognize special populations with increased cardiometabolic risk factors.
  • Review current issues and approaches to global risk assessment.
  • Review the role of biomarkers in cardiovascular disease risk assessment and management.
  • Identify the clinical utility of established and emerging cardiovascular imaging modalities.
  • Evaluate representative clinical cases in the management of patients with dyslipidemia.

Module 3 – Contemporary Management of Dyslipidemia: Therapeutic Lifestyle Change

  • Recognize the role of nutrition and nutritional supplements in the treatment of dyslipidemia.
  • Review characteristics of various diets for the prevention and management of ASCVD.
  • Discuss effective diet and lifestyle strategies for the management of dyslipidemia.
  • Examine the effects of diet and exercise on various lipid measures and weight loss.
  • Review the role of various types of physical activity on dyslipidemia and cardiovascular risk.
  • Evaluate representative clinical cases in the management of patients with dyslipidemia.

Module 4 – Contemporary Management of Dyslipidemia: Pharmacologic Therapy

  • Recognize the role of drug therapy in the management of dyslipidemia.
  • Review the mechanism of action, pharmacokinetics, and efficacy of available FDA approved drugs.
  • Examine clinical trials of lipid-altering drug therapies used in cardiovascular disease prevention.
  • Assess the side effects of lipid-altering drugs to encourage their safe use in cardiovascular disease prevention.
  • Discuss combination therapies for the management of complex lipid disorders and residual risk.
  • Recognize the appropriate use of lipid-altering drugs in special populations.
  • Evaluate representative clinical cases in the management of patients with dyslipidemia.

Module 5 – CLM-SAP 20 - Guidelines: Standards of Care for Dyslipidemia

  • Analyze the 2023 Dyslipidemia guideline.
  • Evaluate representative clinical cases for the management of dyslipidemia.
  • Create evidence-based treatment plans based on recommendations from the 2023 cholesterol guideline.
  • Recognize differences in lipid management recommendations for special populations.
  • Explain recommendations for managing dyslipidemia relative to specific disease states.
  • Describe the principle of lipid management for primary and secondary prevention of ASCVD.
  • Recommend effective diet and lifestyle strategies for dyslipidemia management.
  • Describe statin-associated side effects and identify guideline recommend management strategies.
Credits

Credit Designation
In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Module 1
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.5 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Module 2
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.25 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Module 3
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.5 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Module 4
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Module 5
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.25 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Physician Credit Designation Statement
Module 1:
The National Lipid Association designates this enduring internet activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Module 2:
The National Lipid Association designates this enduring internet activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Module 3:
The National Lipid Association designates this enduring internet activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Module 4:
The National Lipid Association designates this enduring internet activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Module 5:
The National Lipid Association designates this enduring internet activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extentof their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by ACCME.
Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR)
Module 1
Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 3.5 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL0002.
Module 2
Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 4.25 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL0002.
Module 3
Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 4.5 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL0002.
Module 4
Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 3 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL0002.
Module 5
Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 3.25 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL0002.
 

Pharmacists
Module:
Universal Activity Number – JA0007192-0000-23-017-H01-P (Application)
This Activity has been approved for 3.5 contact hour(s) (.35 CEUs) of the Accreditation Council for Pharmacy Education.
Module 2:
Universal Activity Number – JA0007192-0000-23-018-H01-P (Application)
This Activity has been approved for 4.50 contact hour(s) (.45 CEUs) of the Accreditation Council for Pharmacy Education.
Module 3:
Universal Activity Number – JA0007192-0000-23-019-H01-P (Application)
This Activity has been approved for 4.75 contact hour(s) (.475 CEUs) of the Accreditation Council for Pharmacy Education.
Module 4:
Universal Activity Number – JA0007192-0000-23-020-H01-P (Application)
This Activity has been approved for 3 contact hour(s) (.3 CEUs) of the Accreditation Council for Pharmacy Education.
Module 5:
Universal Activity Number- JA0007192-0000-23-015-H01-P (Application)
This Activity has been approved for 3.25 contact hour(3) (.35 CEUs) of the Accreditation Council for Pharmacy Education.

Nursing
Module 1:
The maximum number of hours awarded for this CE activity is 3.4 contact hours. For the advanced practice nurse, this activity has 1 contact hours of pharmacotherapy content.
Module 2:
The maximum number of hours awarded for this CE activity is 4 contact hours. For the advanced practice nurse, this activity has 1 contact hours of pharmacotherapy content.
Module 3:
The maximum number of hours awarded for this CE activity is 4.4 contact hours. For the advanced practice nurse, this activity has 1 contact hours of pharmacotherapy content.
Module 4:
The maximum number of hours awarded for this CE activity is 2.9 contact hours. For the advanced practice nurse, this activity has 2.9 contact hours of pharmacotherapy content.
Module 5:
The maximum number of hours awarded for this CE activity is 3.2 contact hours. For the advanced practice nurse, this activity has 3.2 contact hours of pharmacotherapy content.

  • 18.5 AMA PRA Category 1 Credits™
  • 18.5 CPEUs
  • 19 Contact Hours
  • 1.925 CEUs
  • TARGET AUDIENCE

    PhysicianNursingPharmacistPhysician AssistantAdvanced Practice NurseCardiologistsNursesDietitianNurse Practitioners

    SPECIALITIES

    Cardiology

    RELATED ONLINE COURSES

    Webcast

    Emergency Medicine
    More actions
    US$200

    Webcast

    Pediatrics
    28 AMA PRA Category 1 Credits™
    More actions
    US$910